[1]
“PO50 | Treatment with BTK inhibitors in patients affected by chronic lymphocytic leukemia: safety and hemostasis: L. Gurgoglione, C.A. Piro, I. Scortechini, I. Battilà, M.C. Merlo, A. R. Scortechini, S. Rupoli, A. Poloni | Hematology Unit, AOU delle Marche-Università Politecnica delle Marche, Italy”, Bleeding Thromb Vascul Biol, vol. 4, no. s1, Aug. 2025, doi: 10.4081/btvb.2025.319.